TY - JOUR
T1 - Results of a survey of community-acquired-pneumonia and evaluation of old and new Japanese Respiratory Society guidelines
AU - Gomi, Kazunori
AU - Miki, Makoto
AU - Itabashi, Shigeru
AU - Kikuchi, Tohru
AU - Miur, Shinichi
AU - Shikanai, Toshiki
AU - Inoue, Hiroshi
AU - Takeuchi, Kenichi
AU - Kanda, Akio
AU - Suzukio, Shuzo
AU - Nakagawa, Hideyuki
AU - Hommma, Mitsunobu
AU - Miki, Hiroshi
AU - Abe, Tatsuya
AU - Nishimaki, Katsushi
AU - Saito, Hiroshi
AU - Yasugahir, Hideo
AU - Sayam, Tsuneo
AU - Sat, Makoto
AU - Kikuchi, Ryo
AU - Honda, Yoshihiro
AU - Kawan, Akihiko
AU - Watanabe, Akira
PY - 2007/11
Y1 - 2007/11
N2 - We evaluated the usefulness of domestic and foreign guidelines for the diagnosis and treatment of patients with community-acquired-pneumonia at 23 institutions in 6 prefectures of the Tohoku Area, from December 2003 to November 2004. Based on the old and new Japanese Respiratory Society (JRS) guidelines, we evaluated severity, clinical efficacy and detection of atypical pneumonia. As for severity, the old guidelines led to the diagnosis of an excessive number of 'severe' cases. On the other hand, patients were appropriately diagnosed as having mild, moderate, severe, or very severe disease based on the new JRS guidelines (2005). The severity classification often correlated with the Pneumonia Severity Index (PSI) of the IDSA guidelines. The efficacy rate for patients who were prescribed the recommended drug according to the old JRS guidelines was 85.7% and for those who did not use the recommended drug it was 68.7% (p < 0.001).
AB - We evaluated the usefulness of domestic and foreign guidelines for the diagnosis and treatment of patients with community-acquired-pneumonia at 23 institutions in 6 prefectures of the Tohoku Area, from December 2003 to November 2004. Based on the old and new Japanese Respiratory Society (JRS) guidelines, we evaluated severity, clinical efficacy and detection of atypical pneumonia. As for severity, the old guidelines led to the diagnosis of an excessive number of 'severe' cases. On the other hand, patients were appropriately diagnosed as having mild, moderate, severe, or very severe disease based on the new JRS guidelines (2005). The severity classification often correlated with the Pneumonia Severity Index (PSI) of the IDSA guidelines. The efficacy rate for patients who were prescribed the recommended drug according to the old JRS guidelines was 85.7% and for those who did not use the recommended drug it was 68.7% (p < 0.001).
UR - http://www.scopus.com/inward/record.url?scp=39049084016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39049084016&partnerID=8YFLogxK
M3 - Article
C2 - 18051784
AN - SCOPUS:39049084016
VL - 45
SP - 836
EP - 843
JO - Respiratory Investigation
JF - Respiratory Investigation
SN - 2212-5345
IS - 11
ER -